A study for a 69 year old woman who takes Xeljanz - from FDA reports


4,620 females aged 69 (±5) who take the same drug are studied. This is a personalized study for a 69 year old female patient who has Ra. The study is created by eHealthMe based on reports from FDA.



On May, 15, 2018

4,620 females aged 69 (±5) who take Xeljanz are studied.


Number of reports submitted per year:

Xeljanz for a 69-year old woman.

Information of the patient in this study:

  • Age: 69
  • Gender: female
  • Conditions: Ra
  • Drugs taken:
    • Xeljanz (tofacitinib citrate)

eHealthMe real world results:

Comparison with this patient's adverse outcomes:

  • Dry Mouth: 34 (0.74% of females aged 69 (±5) who take the drug)

As an adverse outcome could be a symptom of a condition, additional studies are listed to help identify the cause: for example, regardless of which drug is taken, how many female HBP patients aged 50 (±5) have nausea

As an adverse outcome could be a side effect of a drug, additional studies are listed to help identify the cause: for example, how many female Aspirin users aged 50 (±5) have nausea

Most common side effects over time

< 1 month:
  1. Diarrhea
  2. Drug ineffective
  3. Pain in extremity
  4. Abdominal pain upper
  5. Urinary tract infection
1 - 6 months:
  1. Drug ineffective
  2. Diarrhea
  3. Headache (pain in head)
  4. Fatigue (feeling of tiredness)
  5. Pain
6 - 12 months:
  1. Drug ineffective
  2. Urinary tract infection
  3. Joint pain
  4. Malaise (a feeling of general discomfort or uneasiness)
  5. Pain
1 - 2 years:
  1. Drug ineffective
  2. Pneumonia
  3. Fall
  4. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  5. Fever
2 - 5 years:
  1. Drug ineffective
  2. Pneumonia
  3. Urinary tract infection
  4. High blood pressure
  5. Septic shock (shock due to blood infection)
5 - 10 years:
  1. Urinary tract infection
  2. Anaemia (lack of blood)
  3. Kyphosis (a condition of over-curvature of the thoracic vertebrae (upper back))
  4. Spondylitic myelopathy (an inflammation of the vertebra)
  5. Nasopharyngitis (inflammation of the nasopharynx)
10+ years:
n/a
not specified:
  1. Drug ineffective
  2. Pain
  3. Headache (pain in head)
  4. Joint pain
  5. Fatigue (feeling of tiredness)
Click here to get more results

Top conditions involved for these people *:

  1. High Blood Pressure : 226 people, 4.89%
  2. Pain : 194 people, 4.20%
  3. Arthritis (form of joint disorder that involves inflammation of one or more joints): 149 people, 3.23%
  4. High Blood Cholesterol : 125 people, 2.71%
  5. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 95 people, 2.06%
Click here to get more results

Top co-used drugs for these people *:

  1. Methotrexate (390 people, 8.44%)
  2. Enbrel (321 people, 6.95%)
  3. Plaquenil (259 people, 5.61%)
  4. Vitamin D (217 people, 4.70%)
  5. Humira (175 people, 3.79%)
Click here to get more results

* Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Want to find out more about the FDA reports used in the study? You can request them from FDA.

You are not alone: Connect with people like you, or share your experience to help people like you.

Related tests

We suggest these affordable tests for self monitoring. You can order them and receive results on eHealthMe. No doctor referral or insurance necessary.

What are the drugs?

What are the conditions?

What are the symtoms?

Could your drugs cause:

Could your conditions cause:



Related studies:

Related publications that referenced our studies

Can you answer these questions?

More questions for: Xeljanz, Ra, Dry mouth

You may be interested in these posts

More posts for: Xeljanz, Ra, Dry mouth

NOTE: The study is based on active ingredients. Other drugs that have the same active ingredients are also considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.